<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34444925</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>12</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Impact of Percutaneous Endoscopic Gastrostomy (PEG) on the Evolution of Disease in Patients with Amyotrophic Lateral Sclerosis (ALS).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2765</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu13082765</ELocationID><Abstract><AbstractText>Dysphagia is a highly prevalent symptom in Amyotrophic Lateral Sclerosis (ALS), and the implantation of a percutaneous endoscopic gastrostomy (PEG) is a very frequent event. The aim of this study was to evaluate the influence of PEG implantation on survival and complications in ALS. An interhospital registry of patients with ALS of six hospitals in the Castilla-Le&#xf3;n region (Spain) was created between January 2015 and December 2017. The data were compared for those in whom a PEG was implanted and those who it was not. A total of 93 patients were analyzed. The mean age of the patients was 64.63 (17.67) years. A total of 38 patients (38.8%) had a PEG implantation. An improvement in the anthropometric parameters was observed among patients who had a PEG from the beginning of nutritional follow-up compared to those who did not, both in BMI (kg/m<sup>2</sup>) (PEG: 0 months, 22.06; 6 months, 23.04; <i>p</i> &lt; 0.01; NoPEG: 0 months, 24.59-23.87; <i>p</i> &gt; 0.05). Among the deceased patients, 38 (40.4%) those who had an implanted PEG (20 patients (52.6%) had a longer survival time (PEG: 23 (15-35.5) months; NoPEG 11 (4.75-18.5) months; <i>p</i> = 0.01). A PEG showed a survival benefit among ALS patients. Early implantation of a PEG produced a reduction in admissions associated with complications derived from it.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>L&#xf3;pez-G&#xf3;mez</LastName><ForeName>Juan J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0003-3144-343X</Identifier><AffiliationInfo><Affiliation>Servicio de Endocrinolog&#xed;a y Nutrici&#xf3;n, Hospital Cl&#xed;nico Universitario de Valladolid, 47003 Valladolid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Endocrinolog&#xed;a y Nutrici&#xf3;n de Valladolid (CIENC), Universidad de Valladolid, 47003 Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ballesteros-Pomar</LastName><ForeName>Mar&#xed;a D</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0002-5729-9926</Identifier><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Endocrinolog&#xed;a y Nutrici&#xf3;n de Valladolid (CIENC), Universidad de Valladolid, 47003 Valladolid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Secci&#xf3;n de Endocrinolog&#xed;a y Nutrici&#xf3;n, Complejo Asistencial Universitario de Le&#xf3;n, 24008 Le&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Torres</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Servicio de Endocrinolog&#xed;a y Nutrici&#xf3;n, Hospital Cl&#xed;nico Universitario de Valladolid, 47003 Valladolid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Endocrinolog&#xed;a y Nutrici&#xf3;n de Valladolid (CIENC), Universidad de Valladolid, 47003 Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pintor-De la Maza</LastName><ForeName>Bego&#xf1;a</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Secci&#xf3;n de Endocrinolog&#xed;a y Nutrici&#xf3;n, Complejo Asistencial Universitario de Le&#xf3;n, 24008 Le&#xf3;n, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penacho-L&#xe1;zaro</LastName><ForeName>Mar&#xed;a A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Servicio de Endocrinolog&#xed;a y Nutrici&#xf3;n, Hospital de El Bierzo, 24404 Ponferrada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palacio-Mures</LastName><ForeName>Jos&#xe9; M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Servicio de Endocrinolog&#xed;a y Nutrici&#xf3;n, Hospital Universitario Rio Hortega, 47012 Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abreu-Pad&#xed;n</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Endocrinolog&#xed;a y Nutrici&#xf3;n, Complejo Asistencial de Segovia, 40002 Segovia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanz-Gallego</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Servicio de Neurolog&#xed;a, Complejo Asistencial de &#xc1;vila, 05071 &#xc1;vila, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Luis-Rom&#xe1;n</LastName><ForeName>Daniel A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0002-1745-9315</Identifier><AffiliationInfo><Affiliation>Servicio de Endocrinolog&#xed;a y Nutrici&#xf3;n, Hospital Cl&#xed;nico Universitario de Valladolid, 47003 Valladolid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Endocrinolog&#xed;a y Nutrici&#xf3;n de Valladolid (CIENC), Universidad de Valladolid, 47003 Valladolid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GRS 1238/A/16</GrantID><Agency>Gerencia de Salud de Castilla y Le&#xf3;n</Agency><Country/></Grant><Grant><GrantID>Beca SCLEDyN 2017-2018</GrantID><Agency>Sociedad Castellano-Leonesa de Endocrinolog&#xed;a, Diabetes y Nutrici&#xf3;n</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000886" MajorTopicYN="N">Anthropometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003680" MajorTopicYN="N">Deglutition Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016145" MajorTopicYN="N">Endoscopy, Digestive System</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005774" MajorTopicYN="N">Gastrostomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044342" MajorTopicYN="N">Malnutrition</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009752" MajorTopicYN="N">Nutritional Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">nutritional status</Keyword><Keyword MajorTopicYN="N">percutaneous endoscopic gastrostomy</Keyword><Keyword MajorTopicYN="N">survival</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>27</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34444925</ArticleId><ArticleId IdType="pmc">PMC8401888</ArticleId><ArticleId IdType="doi">10.3390/nu13082765</ArticleId><ArticleId IdType="pii">nu13082765</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Logroscino G., Traynor B.J., Hardiman O., Chio A., Mitchell D., Swingler R.J., Millul A., Benn E., Beghi E., Eurals F. Incidence of amyotrophic lateral sclerosis in Europe. J. Neurol. Neurosurg. Psychiatry. 2010;81:385&#x2013;390. doi: 10.1136/jnnp.2009.183525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., Kaye W., Raymond J., Punjani R., Larson T., Cohen J., Muravov O., Horton K. Prevalence of Amyotrophic Lateral Sclerosis&#x2014;United States, 2015. MMWR Morb. Mortal. Wkly. Rep. 2018;67:1285&#x2013;1289. doi: 10.15585/mmwr.mm6746a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6746a1</ArticleId><ArticleId IdType="pmc">PMC6289079</ArticleId><ArticleId IdType="pubmed">30462626</ArticleId></ArticleIdList></Reference><Reference><Citation>Worms P.M. The epidemiology of motor neuron diseases: A review of recent studies. J. Neurol. Sci. 2001;191:3&#x2013;9. doi: 10.1016/S0022-510X(01)00630-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00630-X</ArticleId><ArticleId IdType="pubmed">11676986</ArticleId></ArticleIdList></Reference><Reference><Citation>Virgili Casas M.N. La opini&#xf3;n del paciente cuenta: Experiencia en la atenci&#xf3;n nutricional en un equipo multidisciplinar. Nutr. Hosp. 2015;31:56&#x2013;66. doi: 10.3305/nh.2015.31.sup5.9132.</Citation><ArticleIdList><ArticleId IdType="doi">10.3305/nh.2015.31.sup5.9132</ArticleId><ArticleId IdType="pubmed">25938606</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbo Perseguer J., Madejon Seiz A., Romero Portales M., Martinez Hernandez J., Mora Pardina J.S., Garcia-Samaniego J. Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis: Mortality and complications. Neurology. 2018;34:582&#x2013;588. doi: 10.1016/j.nrleng.2018.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrleng.2018.01.002</ArticleId><ArticleId IdType="pubmed">29599075</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvioni CC dos S., Stanich P., Almeida C.S., Oliveira A.S.B. Nutritional care in motor neurone disease/amyotrophic lateral sclerosis. Arq. Neuropsiquiatr. 2014;72:157&#x2013;163. doi: 10.1590/0004-282X20130185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282X20130185</ArticleId><ArticleId IdType="pubmed">24604371</ArticleId></ArticleIdList></Reference><Reference><Citation>Prior-Sanchez I., Herrera-Martinez A.D., Jimenez C.T., Puerta M.J.M., Continente A.J.C., Garcia G.M., Moreno G.G. Percutaneous endoscopic gastrostomy in a myotrophic lateral sclerosis. Experience in a district general hospital. Nutr. Hosp. 2014;30:1289&#x2013;1294. doi: 10.3305/nh.2014.30.6.7808.</Citation><ArticleIdList><ArticleId IdType="doi">10.3305/nh.2014.30.6.7808</ArticleId><ArticleId IdType="pubmed">25433110</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgos R., Bret&#xf3;n I., Cereda E., Desport J.C., Dziewas R., Genton L., Gomes F., J&#xe9;sus P., Leischker A., Muscaritoli M., et al. ESPEN guideline clinical nutrition in neurology. Clin. Nutr. Edinb. Scotl. 2018;37:354&#x2013;396. doi: 10.1016/j.clnu.2017.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2017.09.003</ArticleId><ArticleId IdType="pubmed">29274834</ArticleId></ArticleIdList></Reference><Reference><Citation>The EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis. Andersen P.M., Abrahams S., Borasio G.D., de Carvalho M., Chio A., Van Damme P., Hardiman O., Kollewe K., Morrison K., et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)&#x2014;revised report of an EFNS task force. Eur. J. Neurol. 2012;19:360&#x2013;375. doi: 10.1111/j.1468-1331.2011.03501.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-G&#xf3;mez J.J., Ballesteros-Pomar M.D., Torres-Torres B., De la Maza B.P., Penacho-L&#xe1;zaro M., Palacio-Mures J.M., Abreu-Pad&#xed;n C., L&#xf3;pez-Guzm&#xe1;n A., De Luis-Rom&#xe1;n D.A. Malnutrition at diagnosis in amyotrophic lateral sclerosis (als) and its influence on survival: Using glim criteria. Clin. Nutr. Edinb. Scotl. 2020;40:237&#x2013;244. doi: 10.1016/j.clnu.2020.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2020.05.014</ArticleId><ArticleId IdType="pubmed">32507583</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacyl (Gerencia Regional de Salud. Direcci&#xf3;n General de Asistencia Sanitaria)  Plan Funcional para la atenci&#xf3;n a personas con Esclerosis Lateral Amiotr&#xf3;fica.  [(accessed on 13 July 2021)];2015  Available online:  https://www.saludcastillayleon.es/es/enfermedades-problemas-salud/ela.ficheros/1673692-PLAN-FUNCIONAL-PARA-LA-ATENCION-A-PERSONAS-CON-ELA.pdf.</Citation></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L., World Federation of Neurology Research Group on Motor Neuron Diseases El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Mot. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silva Fink J., Daniel de Mello P., Daniel de Mello E. Subjective global assessment of nutritional status&#x2014;A systematic review of the literature. Clin. Nutr. Edinb. Scotl. 2015;34:785&#x2013;792. doi: 10.1016/j.clnu.2014.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2014.12.014</ArticleId><ArticleId IdType="pubmed">25596153</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J., Leigh P.N., Shaw C.E., Ellis C., Burman R., Al-Chalabi A. Eating-derived pleasure in amyotrophic lateral sclerosis as a predictor of non-oral feeding. Amyotroph. Lateral Scler. Mot. Neuron Disord. 2012;13:555&#x2013;559. doi: 10.3109/17482968.2012.704925.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.704925</ArticleId><ArticleId IdType="pubmed">22871077</ArticleId></ArticleIdList></Reference><Reference><Citation>Morassutti I., Giometto M., Baruffi C., Marcon M.L., Michieletto S., Giometto B., Spinella N., Paccagnella A. Nutritional intervention for amyotrophic lateral sclerosis. Minerva Gastroenterol. Dietol. 2012;58:253&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">22971635</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-G&#xf3;mez J.J., Torres-Torres B., G&#xf3;mez-Hoyos E., Fern&#xe1;ndez-Buey N., Ortol&#xe1;-Buigues A., Castro-Lozano A., Arenillas-Lara J.F., De Luis-Rom&#xe1;n D.A. Influence of a multidisciplinary protocol on nutritional status at diagnosis in amyotrophic lateral sclerosis. Nutrition. 2018;48:67&#x2013;72. doi: 10.1016/j.nut.2017.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2017.11.010</ArticleId><ArticleId IdType="pubmed">29469023</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;rner S., Hendricks M., Kollewe K., Zapf A., Dengler R., Silani V., Petri S. Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): Impact on quality of life and therapeutic options. BMC Neurol. 2013;13:84. doi: 10.1186/1471-2377-13-84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-13-84</ArticleId><ArticleId IdType="pmc">PMC3717067</ArticleId><ArticleId IdType="pubmed">23848967</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson-Tarlton C.S., Benstead T.J., Doucette S. Correlating factors in the recommendation of feeding tubes in the nutritional management of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2016;17:515&#x2013;521. doi: 10.1080/21678421.2016.1213851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1213851</ArticleId><ArticleId IdType="pubmed">27534658</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes G., Santos C.A., Grunho M., Fonseca J. Enteral feeding through endoscopic gastrostomy in amyotrophic lateral sclerosis patients. Nutr. Hosp. 2016;33:561. doi: 10.20960/nh.561.</Citation><ArticleIdList><ArticleId IdType="doi">10.20960/nh.561</ArticleId><ArticleId IdType="pubmed">27759965</ArticleId></ArticleIdList></Reference><Reference><Citation>Pena M.J., Ravasco P., Machado M., Pinto A., Pinto S., Rocha L., de Carvalho M., Pinto H.C. What is the relevance of percutaneous endoscopic gastrostomy on the survival of patients with amyotrophic lateral sclerosis? Amyotroph. Lateral Scler. Mot. Neuron Disord. 2012;13:550&#x2013;554. doi: 10.3109/17482968.2012.684215.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.684215</ArticleId><ArticleId IdType="pubmed">22708872</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Logroscino G., Hardiman O., Swingler R., Mitchell D., Beghi E., Traynor B.G., On Behalf of the Eurals Consortium Prognostic factors in ALS: A critical review. Amyotroph. Lateral Scler. Mot. Neuron Disord. 2009;10:310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Czell D., Bauer M., Binek J., Schoch O.D., Weber M. Outcomes of percutaneous endoscopic gastrostomy tube insertion in respiratory impaired amyotrophic lateral sclerosis patients under noninvasive ventilation. Respir. Care. 2013;58:838&#x2013;844. doi: 10.4187/respcare.02024.</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.02024</ArticleId><ArticleId IdType="pubmed">23107129</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): A prospective cohort study. Lancet Neurol. 2015;14:702&#x2013;709. doi: 10.1016/S1474-4422(15)00104-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)00104-0</ArticleId><ArticleId IdType="pmc">PMC4578147</ArticleId><ArticleId IdType="pubmed">26027943</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsou A.Y., Karlawish J., McCluskey L., Xie S.X., Long J.A. Predictors of emergent feeding tubes and tracheostomies in amyotrophic lateral sclerosis (ALS) Amyotroph. lateral Scler. Mot. Neuron Disord. 2012;13:318&#x2013;325. doi: 10.3109/17482968.2012.662987.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.662987</ArticleId><ArticleId IdType="pmc">PMC4104116</ArticleId><ArticleId IdType="pubmed">22533463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokuda K., Shimizu T., Imamura K., Kawata A., Watabe K., Hayashi M., Nakayama Y., Isozaki E., Nakano I. Predictive factors for prognosis following unsedated percutaneous endoscopic gastrostomy in ALS patients. Muscle Nerve. 2016;54:277&#x2013;283. doi: 10.1002/mus.25051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25051</ArticleId><ArticleId IdType="pubmed">26799526</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagashima K., Furuta N., Makioka K., Fujita Y., Ikeda M., Ikeda Y. An analysis of prognostic factors after percutaneous endoscopic gastrostomy placement in Japanese patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 2017;376:202&#x2013;205. doi: 10.1016/j.jns.2017.03.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.03.029</ArticleId><ArticleId IdType="pubmed">28431613</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J., Dupuis L., Petri S., Kollewe K., Abdulla S., Wolf J., Weber M., Czell D., Burkhardt C., Hanisch F., et al. Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: A prospective observational study. J. Neurol. 2015;262:849&#x2013;858. doi: 10.1007/s00415-015-7646-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7646-2</ArticleId><ArticleId IdType="pubmed">25618254</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarfaty M., Nefussy B., Gross D., Shapira Y., Vaisman N., Drory V.E. Outcome of percutaneous endoscopic gastrostomy insertion in patients with amyotrophic lateral sclerosis in relation to respiratory dysfunction. Amyotroph. Lateral Scler. Front. Degener. 2013;14:528&#x2013;532. doi: 10.3109/21678421.2013.812659.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.812659</ArticleId><ArticleId IdType="pubmed">23886339</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R., Huang R., Chen D., Song W., Zeng Y., Zhao B., Zhou N., Shang H.-F. Causes and places of death of patients with amyotrophic lateral sclerosis in south-west China. Amyotroph. lateral Scler. Mot. Neuron Disord. 2011;12:206&#x2013;209. doi: 10.3109/17482968.2011.572979.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.572979</ArticleId><ArticleId IdType="pubmed">21506897</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez Puerta R., Yuste Ossorio E., Narbona Galdo S., Perez Izquierdo N., Penas Maldonado L. Amyotrophyc lateral sclerosis; gastrointestinal complications in home enteral nutrition. Nutr. Hosp. 2013;28:2014&#x2013;2020. doi: 10.3305/nutrhosp.v28in06.6630.</Citation><ArticleIdList><ArticleId IdType="doi">10.3305/nutrhosp.v28in06.6630</ArticleId><ArticleId IdType="pubmed">24506382</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Hubbard J., Rudnicki S.A., Johansen C.S., Dalton K., Heiman-Patterson T., Forshew D.A., Wills A.-M. Survey of current enteral nutrition practices in treatment of amyotrophic lateral sclerosis. E-SPEN J. 2013;8:e25&#x2013;e28. doi: 10.1016/j.clnme.2012.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnme.2012.11.003</ArticleId><ArticleId IdType="pmc">PMC4283833</ArticleId><ArticleId IdType="pubmed">25568837</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>